Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Contemp Clin Trials. 2020 Sep 15;98:106150. doi: 10.1016/j.cct.2020.106150

Table 2.

Schedule of Assessments

Primary Screening Secondary Screening Baseline Week 8 Week 16 Week 24c Week 48
Assessment of basic eligibility criteria
Symptom quantification
Cognitive testing
Functional testing
Neurological exam
Geriatric syndromes assessment Clinical labs
Primary outcome measures
Mediators & moderators
Clinical labsa MRIb
Primary outcome measures
Mediators & moderators
Clinical labsa MRIb
Primary outcome measures
Mediators & moderators
Clinical labsa MRIb
Primary outcome measures
Mediators & moderators
Primary outcome measures
Mediators & moderators
Neurological exam
Clinical labsa
a

Plasma HIV RNA and lymphocyte subset panel only

b

n=30 participants per arm

c

Control participants only